Table 1

 Characteristics of study patients

Patient noAge (years)SexSmokingOnset*Quality of lung fibrotic lesionsBAL lymphocytes(%)TreatmentObservation period(months)Response to steroid treatment
BAL, bronchoalveolar lavage; M, male; F, female; S, current smoker; NS, non-smoker; Ex, ex-smoker; BOOP, bronchiolitis obliterans organising pneumonia; NSIP, non-specific interstitial pneumonia; UIP, usual interstitial pneumonia; CS, corticosteroid; IS, immunosuppressant.
*Chronic bird fancier’s lung (BFL) can be subgrouped clinically into two types: one subgroup develops interstitial pulmonary fibrosis after recurrent acute episodes (recurrent BFL) and the other subgroup has no history of acute episodes but has a slowly progressive chronic respiratory disease (insidious BFL).
165MSRecurrentBOOP-like66.2CS77Favourable
275FNSRecurrentBOOP-like83.0CS77Favourable
349FSRecurrentCellular NSIP-like73.0CS84Favourable
445MExRecurrentCellular NSIP-like74.5CS114Favourable
545MExRecurrentCellular NSIP-like82.0CS98Favourable
655FNSRecurrentCellular NSIP-like86.0CS72Favourable
764FNSInsidiousCellular NSIP-like74.3CS64Favourable
865FNSRecurrentFibrotic NSIP-like57.7CS138Favourable
960MNSRecurrentFibrotic NSIP-like76.0CS60Failure
1061FExRecurrentFibrotic NSIP-like51.3CS66Stable
1150FNSRecurrentFibrotic NSIP-like62.2CS+IS63Failure (died)
1264FNSInsidiousFibrotic NSIP-like27.0None
1353MExInsidiousFibrotic NSIP-like28.0CS+IS60Failure (died)
1458MExInsidiousFibrotic NSIP-like12.2CS+IS16Failure (died)
1556MSInsidiousFibrotic NSIP-like11.8CS+IS48Failure (died)
1654MSInsidiousUIP-like18.2None
1749MSInsidiousUIP-like7.0CS+IS7Failure (died)
1872FNSInsidiousUIP-like38.8CS42Stable
1965MExInsidiousUIP-like22.3CS+IS29Failure (died)
2067MExInsidiousUIP-like10.2CS+IS12Failure (died)
2170MSInsidiousUIP-like32.0None
2269MSInsidiousUIP-like16.5CS+IS25Failure (died)
2364MExInsidiousUIP-like17.0CS36Stable
2469FNSInsidiousUIP-like9.0CS+IS6Failure (died)
2565FNSInsidiousUIP-like15.0CS+IS48Failure (died)
2668MSInsidiousUIP-like24.1CS48Favourable